Manufacturing process of Anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance

Author： Morrica A.   Nardini C.   Falbo A.   Bailey A.C.   Bucci E.  

Publisher： Elsevier

ISSN： 1045-1056

Source： Biologicals, Vol.31, Iss.3, 2003-09, pp. : 165-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Use of uniform designs in combination with neural networks for viral infection process development

By  

BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol. 31, Iss. 2, 2015-03 ,pp. : 532-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

The interactions between antithrombin III, thrombin and surface immobilized heparin

By Van Delden C.J.   Engbers G.H.M.   Feijen J.  

Journal of Biomaterials Science, Polymer Edition, Vol. 7, Iss. 11, 1996-01 ,pp. : 989-1004

Taylor & Francis Ltd

Access to resources Recommend Favorite

Re-Use of Established Drugs for Anti-Metastatic Indications

By Entschladen Frank   Thyssen Dane A.   Drell David W.  

Cells, Vol. 5, Iss. 1, 2016-01 ,pp. : 2-2

MDPI

Access to resources Recommend Favorite

Anti-Viral Drugs for Human Adenoviruses

By Waye Mary Miu Yee   Sing Chor Wing  

Pharmaceuticals, Vol. 3, Iss. 10, 2010-10 ,pp. : 3343-3354

MDPI

Access to resources Recommend Favorite

Low pH, caprylate incubation as a second viral inactivation step in the manufacture of albumin - Parametric and validation studies

By Johnston A.   Uren E.   Johnstone D.   Wu J.  

Biologicals, Vol. 31, Iss. 3, 2003-09 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite